<img alt="" height="1" width="1" />
FDA Reviewer Questions Results of Key Avandia Trial
U.S. News & World Report
FRIDAY, July 9 (HealthDay News) -- One step ahead of a planned government review of the safety of Avandia, new doubts surfaced Friday on a key trial that helped keep the blockbuster diabetes drug on the market. ...
FDA to consider fate of diabetes drug AvandiaUSA Today
FDA Staff Raise Concerns About Avandia Safety, Glaxo StudyWall Street Journal
Pull Controversial Drug from Market, Say Some FDA StaffABC News
AFP -BusinessWeek -Consumer Affairs
all 686 news articles &raquo;